A secondary metabolite of Limosilactobacillus reuteri R2lc drives strain-specific pathology in a spontaneous mouse model of multiple sclerosis

A secondary metabolite of Limosilactobacillus reuteri R2lc drives strain-specific pathology in a spontaneous mouse model of multiple sclerosis

Summary: Limosilactobacillus reuteri is an immunomodulatory bacterium enriched in non-industrialized microbiomes, making it a therapeutic candidate for chronic diseases. However, effects of L. reuteri strains in mouse models of multiple sclerosis have been contradictory. Here, we show that treatment...

Full description

Saved in:
Bibliographic Details
Main Authors: Dale Archer, María Elisa Pérez-Muñoz, Stephanie Tollenaar, Simona Veniamin, Naomi Hotte, Christopher C. Cheng, Kristoff Nieves, Jee-Hwan Oh, Lilian Morceli, Susan Muncner, Daniel R. Barreda, Gurumoorthy Krishnamoorthy, Christopher Power, Jan-Peter van Pijkeren, Jens Walter
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Cell Reports
Subjects:
CP: Microbiology
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124725000920
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items